Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Larner

Showing results (261-270 of 334) with videos related to

Pageof 34
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphataseG T Galasko, S Abe, K Lilley, et al.
Archives of Biochemistry and Biophysics|July 1, 1992
Insulin mediator stimulation of pyruvate dehydrogenase phosphatasesK Lilley, C Zhang, C Villar-Palasi, et al.
International Journal of Clinical Practice|April 28, 2005
Single-photon emission computed tomography perfusion imaging in the differential diagnosis of dementia: a retrospective regional auditM Doran, S Vinjamuri, J Collins, et al.
Molecular and Cellular Biochemistry|March 1, 1985
Mechanisms of insulin resistance in cultured fibroblasts from a patient with leprechaunism: resistance to proteolytic activation of glycogen synthase by trypsinJ W Craig, J Larner, E F Locker, et al.
Stroke|March 6, 1999
Spatz-Lindenberg disease: a rare cause of vascular dementiaA J Larner, D Kidd, P Elkington, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1996
No change in insulin mediators in human skeletal muscle during isometric contraction or recoveryA Katz, E Hultman, L Huang, et al.
Biochemical and Biophysical Research Communications|March 20, 1999
A model phosphatase 2C --> phosphatase 1 activation cascade via dual control of inhibitor-1 (INH-1) and DARPP-32 dephosphorylation by two inositol glycan putative insulin mediators from beef liverL C Huang, D Heimark, J Linko, et al.
International Journal of Clinical Practice|November 9, 2000
Systemic Weber-Christian disease complicated by partial transverse myelopathyA J Larner, B Marshall, R C Ma, et al.
Scandinavian Journal of Medicine & Science in Sports|March 9, 2017
A multistudy examination of organizational stressors, emotional labor, burnout, and turnover in sport organizationsR J Larner, C R D Wagstaff, R C Thelwell, et al.
American Journal of Clinical Oncology|December 18, 1998
A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiformeJ Larner, J Jane, E Laws, et al.
Pageof 34

Showing results (261-270 of 334) with videos related to

Sort By:
Pageof 34
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Circulating factors and insulin resistance. II. The action of the novel myo-inositol cyclic 1,2-inositol phosphate phosphoglycan insulin antagonist from human plasma in regulating pyruvate dehydrogenase phosphataseG T Galasko, S Abe, K Lilley, et al.
Archives of Biochemistry and Biophysics|July 1, 1992
Insulin mediator stimulation of pyruvate dehydrogenase phosphatasesK Lilley, C Zhang, C Villar-Palasi, et al.
International Journal of Clinical Practice|April 28, 2005
Single-photon emission computed tomography perfusion imaging in the differential diagnosis of dementia: a retrospective regional auditM Doran, S Vinjamuri, J Collins, et al.
Molecular and Cellular Biochemistry|March 1, 1985
Mechanisms of insulin resistance in cultured fibroblasts from a patient with leprechaunism: resistance to proteolytic activation of glycogen synthase by trypsinJ W Craig, J Larner, E F Locker, et al.
Stroke|March 6, 1999
Spatz-Lindenberg disease: a rare cause of vascular dementiaA J Larner, D Kidd, P Elkington, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1996
No change in insulin mediators in human skeletal muscle during isometric contraction or recoveryA Katz, E Hultman, L Huang, et al.
Biochemical and Biophysical Research Communications|March 20, 1999
A model phosphatase 2C --> phosphatase 1 activation cascade via dual control of inhibitor-1 (INH-1) and DARPP-32 dephosphorylation by two inositol glycan putative insulin mediators from beef liverL C Huang, D Heimark, J Linko, et al.
International Journal of Clinical Practice|November 9, 2000
Systemic Weber-Christian disease complicated by partial transverse myelopathyA J Larner, B Marshall, R C Ma, et al.
Scandinavian Journal of Medicine & Science in Sports|March 9, 2017
A multistudy examination of organizational stressors, emotional labor, burnout, and turnover in sport organizationsR J Larner, C R D Wagstaff, R C Thelwell, et al.
American Journal of Clinical Oncology|December 18, 1998
A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiformeJ Larner, J Jane, E Laws, et al.
Pageof 34